Form 4 for NPCE NeuroPace Inc
Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-07 · accession 0001209191-22-053273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-11 | 2022-10-07 | NPCE | Morrell Martha | Chief Medical Off | M - OptEx | $0.03 | +576 | 56.8K | +1% | +$17.28 |
| DM | 2022-10-11 | 2022-10-07 | NPCE | Morrell Martha | Chief Medical Off | M - OptEx | $0.00 | -576 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-07 | M | A | 384 | $0.03 | 57,164 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-07 | M | A | 192 | $0.03 | 56,780 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-10-07 | M | D | 384 | $0.00 | 0 | D | $0.03 · — to 2023-03-08 | 384 Common Stock | (F1) The shares underlying the option are fully vested. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-10-07 | M | D | 192 | $0.00 | 0 | D | $0.03 · — to 2022-11-13 | 192 Common Stock | (F1) The shares underlying the option are fully vested. |